The DOI matches its Crossref record.
Hepatocellular carcinoma in Budd–Chiari syndrome: characteristics and risk factors
Abstract
Background and aim: To analyse the characteristics of and the factors associated with the development of hepatocellular carcinoma (HCC) in patients with Budd–Chiari syndrome (BCS). Patients and methods: 97 consecutive patients with BCS and a follow-up ⩾1 year were evaluated retrospectively. Liver nodules were evaluated using serum α-fetoprotein (AFP) level and imaging features (CT/MRI). Biopsy of nodules was obtained when one of the following criteria was met: number ⩽3, diameter ⩾3 cm, heterogeneity, washout on portal venous phase, increase in size on surveillance, or increase in AFP level. Results: Patients were mainly Caucasian (69%) and female (66%). Mean age at the diagnosis of BCS was 35.8 (SE 1.2 years), and median follow-up 5 years (1–20 years). The inferior vena cava (IVC) was obstructed in 13 patients. Liver nodules were found in 43 patients, 11 of whom had HCC. Cumulative incidence of HCC during follow-up was 4%. Liver parenchyma adjacent to HCC showed cirrhosis in nine patients. HCC was associated with male sex (72.7% v 29.0%, p = 0.007); factor V Leiden (54.5% v 17.5%, p = 0.01); and IVC obstruction (81.8% v 4.6%, p<0.001). Increased levels of serum AFP were highly accurate in distinguishing HCC from benign nodules: PPV = 100% and NPV = 91% for a cut-off level of 15 ng/ml. Conclusion: The incidence of HCC in this large cohort of BCS patients was similar to that reported for other chronic liver diseases. IVC obstruction was a major predictor for HCC development. Serum AFP appears to have a higher utility for HCC screening in patients with BCS than with other liver diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Vascular disorders of the liver # †
DeLeve, L. D., Valla, D.-C., & Garcia-Tsao, G. (2009) · Hepatology · doi:10.1002/hep.22772 · Cited by 978
Self-citationEASL Clinical Practice Guidelines: Vascular diseases of the liver
(2016) · Journal of Hepatology · doi:10.1016/j.jhep.2015.07.040 · Cited by 808
Northup, P. G., Garcia‐Pagan, J. C., Garcia‐Tsao, G., Intagliata, N. M., Superina, R. A., Roberts, L. N., Lisman, T., & Valla, D. C. (2021) · Hepatology · doi:10.1002/hep.31646 · Cited by 667
Self-citationPorto-sinusoidal vascular disease: proposal and description of a novel entity
De Gottardi, A., Rautou, P.-E., Schouten, J., Rubbia-Brandt, L., Leebeek, F., Trebicka, J., Murad, S. D., Vilgrain, V., Hernandez-Gea, V., Nery, F., et al. (2019) · The Lancet Gastroenterology & Hepatology · doi:10.1016/s2468-1253(19)30047-0 · Cited by 318
Self-citationChanging trends in malignant transformation of hepatocellular adenoma
Farges, O., Ferreira, N., Dokmak, S., Belghiti, J., Bedossa, P., & Paradis, V. (2011) · Gut · doi:10.1136/gut.2010.222109 · Cited by 299
Self-citation
Metadata
- Authors
- Moucari, R., Rautou, P.-E., Cazals-Hatem, D., Geara, A., Bureau, C., Consigny, Y., Francoz, C., Denninger, M.-H., Vilgrain, V, Belghiti, J., Durand, F., Valla, D., & Plessier, A.
- Venue
- Gut
- Publisher
- BMJ
- Published
- 2008-01-24
- Volume
- 57
- Issue
- 6
- Pages
- 828-835
- ISSN
- 0017-5749 (ISSN-L)
- 1468-3288
- OpenAlex
- W2128637211
- Cited by
- 186
- References
- 0
- FWCI
- 7.62
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Hepatocellular carcinoma in Budd–Chiari syndrome: characteristics and risk factors. https://app.cochat.ai/papers/10.1136/gut.2007.139477
- The paper
- Moucari, R., Rautou, P.-E., Cazals-Hatem, D., Geara, A., Bureau, C., Consigny, Y., Francoz, C., Denninger, M.-H., Vilgrain, V, Belghiti, J., Durand, F., Valla, D., & Plessier, A. (2008). Hepatocellular carcinoma in Budd–Chiari syndrome: characteristics and risk factors. Gut. https://doi.org/10.1136/gut.2007.139477
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.